Your Location：
Home >
Browse articles >
Pharmacodynamic Basis of Jinqi Jiangtang Tablets in Treatment of Type 2 Diabetes Based on LC-MS and Molecular Docking Strategy
Pharmacodynamic Basis of Jinqi Jiangtang Tablets in Treatment of Type 2 Diabetes Based on LC-MS and Molecular Docking Strategy
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 3, Pages: 125-136(2020)
DOI： 10.13422/j.cnki.syfjx.20192414
Scan QR Code
Full Text(HTML)
Figs( 4 ) Tabs( 2 )
References
Publication Info
Metrics
75
Views
69
Downloads
1
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Analysis of Pharmacodynamic Material Basis， Mechanisms， and Efficacy-related Quality Markers of Puerariae Lobatae Radix and Puerariae Thomsonii Radix with Different Therapeutic Effect
Traditional Chinese Medicine Intervening Signaling Pathways Related to Type 2 Diabetes Mellitus Complicated with Hyperlipidemia： A Review
Role of Modified Sanjiasan in Improving Ovarian Dysfunction in Diabetic Mice via Modulating Inflammatory Mechanism and Microangiogenesis
Mechanism of Qijiang Yimai Prescription in Delaying Vascular Aging of Type 2 Diabetes Mellitus Rats by Regulating FGF21/AMPK Pathway and Enhancing Mitophagy
Regulatory Effect and Mechanisms of Liuhuang Zhike Prescription on Glycemic Control in db/db Mice via AMPK/Akt/GSK-3β Signaling Pathway
Related Author
MENG Xiaowei
YANG Zhenzhen
WU Wenting
LIU Ronghua
GUAN Yongmei
OUYANG Hui
HUANG Liping
WANG Yaqi
Related Institution
Jiangxi University of Chinese Medicine
Shaanxi University of Chinese Medicine
Key Laboratory of Health Cultivation of the Ministry of Education， Beijing University of Chinese Medicine
Key Laboratory of Health Cultivation of Beijing， Beijing University of Chinese Medicine
Science and Technology Department， Beijing University of Chinese Medicine
Chat
